Granite Point Capital Management, L.P. Gain Therapeutics, Inc. Transaction History

Granite Point Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$7.01 - $10.26 $1.09 Million - $1.6 Million	-155,709 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.96 - $15.8 $620,847 - $1.09 Million	-69,291 Reduced 30.8%	155,709 $1.56 Million
Q1 2021 May 12, 2021	BUY	$11.2 - $14.92 $2.52 Million - $3.36 Million	225,000 New	225,000 $3.36 Million

2.39M

10K

Ticker GANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,883,400
Market Cap $19M
Description
Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.